Factors That Virtually Exclude Cervical Cancer at Colposcopy

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer screening relies on cytology and human papillomavirus (HPV) testing.
• Colposcopy is a key procedure for evaluating abnormal screening results.
• Accurate risk assessment at colposcopy is crucial for patient management.

Purpose of the Study:

• To determine the risk of invasive cervical cancer during colposcopy.
• To analyze risk based on patient age, cervical cytology, and colposcopic findings.

Main Methods:

• Retrospective review of electronic medical records from colposcopy clinics.
• Chart review of women diagnosed with cervical cancer post-colposcopy.
• Analysis of data from 27,381 colposcopy procedures performed between 1996 and 2013.

Main Results:

• Invasive cervical cancer was diagnosed in 0.5% of women undergoing colposcopy.
• The risk of cancer was 0.07% for women under 30 and 0.17% for those with Cytology-Lo results.
• The combined risk of cancer for women under 30 with Cytology-Lo was significantly lower at 0.01%.

Conclusions:

• A normal colposcopic examination, Cytology-Lo, or age under 30 do not exclude cervical cancer.
• The combination of age under 30 and Cytology-Lo virtually excludes invasive cervical cancer.
• Risk stratification aids in managing women undergoing colposcopy for abnormal cervical cytology.